Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tight junction and adhesion proteins are a diverse group of transmembrane and cytoplasmic proteins that mediate cell-cell contact and maintain the structural integrity of epithelial and endothelial barriers (Source: StatPearls, NBK541079). Tight junctions, composed of proteins like claudins, occludins, and zonula occludens, regulate the paracellular pathway, controlling the flow of ions and solutes while preventing the entry of pathogens (Source: PMID: 28215312). Adhesion proteins, such as cadherins and integrins, provide mechanical strength and facilitate intracellular signaling pathways that govern cell growth, differentiation, and migration (Source: UniProt). In many diseases, particularly cancer and inflammatory conditions, these proteins are dysregulated, leading to leaky barriers or facilitating the epithelial-mesenchymal transition (EMT) and subsequent metastasis (Source: PMID: 33431110). Therapeutic strategies targeting these proteins include monoclonal antibodies that induce cell death in claudin-expressing tumors or small molecules that modulate barrier permeability for enhanced drug delivery (Source: DrugBank). However, because these proteins are widely expressed in healthy tissues, therapeutic targeting requires high specificity to avoid systemic barrier disruption and associated toxicities (Source: PMID: 30635924).
Antibody-dependent cellular cytotoxicity (ADCC), inhibition of leukocyte trafficking, modulation of paracellular permeability, and competitive antagonism of cell-surface adhesion receptors.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tight junction and adhesion proteins.